Sweat
Also known as: Perspiration, Bromhidrosis
Methodology & AI Transparency ⓘ
Sweat Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Sweat is a clear, salty liquid produced by glands in your skin.
- 2 Real-world patient consensus: Synonyms for Sweat (R61): Perspiration, Bromhidrosis (Thyroid & Endocrine).
- 3 Typical cash cost range: Workup highlights for Sweat (R61): electrolyte-mineral balance monitoring [Sweat R61].
- 4 Top reported side effects / signs: Longitudinal Sweat monitoring tracks Thyroid-Stimulating Hormone (TSH) [Sweat R61] toward 0.8 – 2.5 mIU/L (R61).
Ask our AI Specialists anything about Sweat
What Is Sweat?
Sweat is a clear, salty liquid produced by glands in your skin. Sweating is how your body cools itself. You sweat mainly under your arms and on your feet and palms. When sweat mixes with bacteria on your skin, it can cause a smell. Bathing regularly and using antiperspirants or deodorants can help control the odor. Sweating a lot is normal when it is hot or when you exercise, are anxious, or have a fever. It also happens during menopause. If you often sweat too much, it's called hyperhidrosis. Causes include thyroid or nervous system disorders, low blood sugar, or another health problem.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Sweat (R61) center on hypothalamic-pituitary-endocrine feedback dysregulation [Sweat R61]. Cross-referenced with NIH MeSH (Sweat), targeted thyroid & endocrine interventions aim to normalize Thyroid-Stimulating Hormone (TSH) [Sweat R61].
Common Symptoms & Clinical Signs
- • Presentation of Sweat (R61): unexplained shifts in in Sweat (R61: cold/heat tolerance, basal)
- • Secondary Sweat clinical sign: persistent fatigue, sluggish in Sweat (R61: morning waking, or)
- • Symptom flares in Sweat correlating with Thyroid-Stimulating Hormone (TSH) [Sweat R61] deviation outside 0.8 – 2.5 mIU/L (R61)
- • Functional thyroid & endocrine impact requiring electrolyte-mineral balance monitoring [Sweat R61] evaluation (R61)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Sweat Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | R61 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Thyroid, Adrenal & Endocrine Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Thyroid-Stimulating Hormone (TSH) [Sweat R61] | 0.8 – 2.5 mIU/L (R61) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Free Thyroxine (Free in Sweat (R61: T4) & Free) | FT4 1.1–1.6 ng/dL; FT3 3.0–4.0 pg/mL (R61) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Morning Serum Cortisol in Sweat (R61: (8 AM)) | 10 – 18 mcg/dL (R61) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Sweat
Treatment selection for Sweat depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Sweat)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on A novel lotion formulation of 20% oxybutynin hydrochloride for the treatment of In patients with PPHH, 20% OL is superior to placebo in reducing palmar sweat volume. Journal of the American Academy of Dermatology • 2023-07-15 • Phase III Randomized Trial | N = 144 | 88/100 | PMID 36990320 ↗ |
| Can This Approach Help? Inside the Latest Research on Oral micronized progesterone for perimenopausal night sweats and hot flushes a Perimenopausal night sweats ± hot flushes are variable; this RCT was underpowered but could not exclude a minimal clinically important VMS benefit. Scientific reports • 2023-06-05 • Phase III Randomized Trial | N = 189 | 88/100 | PMID 37277418 ↗ |
| Can This Approach Help? Inside the Latest Research on A multicentre randomised controlled trial of a guided self-help cognitive ISRCTN reference 58720120 . Trials • 2023-07-10 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 37430353 ↗ |
Sweat Patient Community & “People Like Me” Threads
Filter Sweat community threads and patient logs by age, biological sex, dosage, and treatment duration.